1

Buletin farmasi hospital tumpat

Ju

la

i 2

01

4

Bu

le

tin

F

arm

asi

PANDUAN PENGGUNAAN UBAT TITIS MATA (ENGLISH VERSION) M/SURAT : 2

PANDUAN PENGGUNAAN SALAP MATA (ENGLISH VERSION) M/SURAT : 3

PANDUAN PENGGUNAAN UBAT TITIS TELINGA (ENGLISH VERSION) M/SURAT : 4

PANDUAN PENGGUNAAN UBAT TITIS HIDUNG (ENGLISH VERSION) M/SURAT : 5

NEW MEDICATION : SQUALAMINE EYE DROPS M/SURAT : 6-7

5S HOSPITAL TUMPAT M/SURAT : 8-9

WARGA FARMASI HOSPITAL TUMPAT & LAIN-LAIN AKTIVITI M/SURAT : 10-17

2

1. Wash your hands.

2. Dry them with a clean towel or tissue.

3. Read the medication label.

4. Shake the bottle as this is indicated on the bottle or it is directed by the doctor.

5. Unscrew the cap of the bottle (for bottles with an integrated dropper, draw some liquid into the dropper).

6. Lie down or tilt your head back and gently pull your lower eyelid down.

7. Hold the dropper (tip down) with the other hand, as close to the eye as possible without touching it

8. While looking up, gently squeeze the dropper so that a single drop falls into the pocket made by the l lower eyelid. Remove your index finger from the lower eyelid

9. Close your eyes slowly and gently press a finger against the inside corner of each eye and keep them closed for approximately 1 minute to allow the medication to absorb. Straighten your head and wipe away any extra liquid.

10. If you have more than one drop of medicine to put in your eyes, wait about 5 minutes after the first medicine.

2

3

1. Wash your hands.

2. Dry them with a clean towel or tissue.

3. Read the medication label.

4. Lie down or tilt your head back and gently pull your lower eyelid down.

5. Carefully, place a line (1cm) of ointment inside the lower lid while being careful not to touch your eye with the tip of the tube.

6. Your vision can become blurry for a few moments, but it will clear quickly.

7. Close you eyes slowly and gently press a finger against the inside corner of each eye and keep them closed for approximately 1 minute to allow the medication to absorb.

8. Straighten your head and wipe away any extra ointment.

If you are prescribed both eye drop and eye ointment together use the eye drop first.

3

4

1. Wash your hands.

2. Dry them with a clean towel or tissue.

3. Read the medication label.

4. Unscrew the cap of the bottle (for bottles with an integrated dropper, draw some liquid into the dropper).

5. Lie on your side or tilt your head over so that the ear which needs the drops is facing upwards.

6. Pull your earlobe upwards (or if giving to a child younger than 3 years of age, pull backward and downward) to open the ear canal and squeeze/drop the correct number of drops into the ear.

7. Keep your head tilted for about five minutes so that the drops can spread into the ear.

8. Straighten your head and wipe away any extra liquid.

9. Replace the cap on the bottle.

4

5

1. Gently blow your nose so that your nostrils are clean.

2. Wash your hands.

3. Dry them with a clean towel or tissue.

4. Read the medication label.

5. Unscrew the cap of the bottle (for bottles with an integrated dropper, draw some liquid into the

dropper).

6. Tilt your head back.

7. Hold the bottle or dropper above your nostrils and gently squeeze the correct number of drops into the nostrils.

REFERENCES:

1. American Society of Health-System Pharmacists.

Available from: http://www.safemedication.com/safemed/MedicationTipsTools/HowtoAdminister

2. Know your medicine: Self-care & Self-medication; Pamphlet.

Available from: http://www.knowyourmedicine.gov.my

By: Owi Siew Ai

5

6

Squalamine Eye Drops

What is Squalamine?

Squalamine is an anti-angiogenic amino sterol derived from cartilage

of the dogfish shark, Squalus acanthus..

Mechanism of Action

It blocks ion transporters that regulate cell function by controlling

pH and metabolism.

When bound to calmodulin, squalamine also blocks the action of

vascular endothelial growth factor (VEGF) and integrin

expression,thereby inhibiting angiogenesis (stop formation of new

blood vessel) in the retina and macula.

A History of Squalamine

Research

Initially, Genaera Corporation

developed squalamine as an intravenous formulation for wet-age

related macular degeneration (AMD) a degenerative retinal eye disease that

causes a progressive, irreversible, severe loss of central vision.

After Phase 1 and Phase 2 clinical trials, this project was discontinued due to

financial and subject-recruitment issues in 2007.

Squalamine has been shown to inhibit new vessel formation without significant regression of existing

lesions, and, depending on the lesion composition, combination with adjunctive

therapies may be appropriate.

Then this project was acquired by Ohr Pharmaceutical, which continued the

development of squalamine in a topical eye drop formulation.

This study has entered phase II clinical trial to evaluate the safety and efficacy of topical ophthalmic

squalamine lactate eye drops and expected to complete in December 2014.

6

7

Current Treatment

VEGF inhibition therapy is the best available treatment for wet AMD but is limited by the need for

repeated intravitreal injections.

Options currently include either a full-length recombinant monoclonal antibody (bevacizumab/

Avastin) or a highly afnitized fragment of the antibody (ranibizumab/Lucentis), or a pegylated

aptamer (pegabtanib sodium/Macugen).

Conclusion

Thus, with the development of squalamine eye drop which designed for self administration, may

provide several potential advantages over the FDA approved current standards of care, which

require intravitreal injections directly into the eye.

References

Chakravarthy, U., Soubrane, G., Bandello, F., Chong, V., Creuzot-Garcher, C., & Dimitrakos, S. A. (2006).

Evolving European guidance on the medical management of neovascular age related macular

degeneration. Br J Ophthalmol , 11881196.

Emerson, M. V., & Lauer, A. K. (2008). Current and emerging therapies for the treatment. Clinical

Ophthalmology , 377-388.

http://clinicaltrials.gov/ct2/show/NCT01678963

http://www.visionaware.org/blog/visionaware-blog/a-new-clinical-trial-squalamine-eye-drops-for-wet-

amd-and-retinal-vein-occlusion/12

VS

By : Hasanah Muhammad

7

8 8

9 9

10

SELAMAT DATANG & SELAMAT BERKHIDMAT DI HOSP. TUMPAT

Menamatkan latihan Provisional Registered Pharmacist (PRP) di HRPZ II pada 2012

Memegang Ijazah Sarjana Muda Farmasi USM.

Mula melapor diri di Hospital Tumpat pada Januari 2013

Melapor diri di Hospital Tumpat pada Oktober 2013.

Menamatkan latihan Provisional Registered Pharmacist (PRP) di HRPZ II sebelum bertugas di Hospital Tumpat.

Merupakan pemegang Ijazah Sarjana Muda Farmasi UIAM

Mula berkhidmat di Hospital Tumpat pada 2 Mac 2014

Sebelum ini telah berkhidmat di KK Putrajaya Presint 9 selama 2 tahun (2012-2014)

Lulusan Diploma Penolong Pegawai Farmasi dari KPJ International University

Mula berkhidmat di Hospital Tumpat pada Mei 2013

Telah berkhidmat di Klinik Kesihatan Mahligai, Klinik Kesihatan Wakaf Che Yeh, dan Hospital Tengku Anis

Lulusan Diploma Pembantu Farmasi Makmal & Stor Petaling Jaya

PN NORDALILA SHAFII, PEN. PEG. FARMASI U29

PN LOW GIM LAY, PEN. PEG. FARMASI U32

CIK OWI SIEW AI, PEGAWAI FARMASI U41

PN HASANAH MUHAMMAD, PEGAWAI FARMASI U41

2005-2011 mula berkhidmat di Hospital Permai Johor Bharu

2011 2013 bertukar ke KK Kuala Balah Jeli, Kelantan.

Mula berkhidmat di Hospital Tumpat pada Mei 2013.

Lulusan Diploma Pembantu Farmasi Kolej Perubatan DiRaja Perak

EN MOHD RIZALMIE MUHD NOR, PEN. PEG. FARMASI u29

10

11

Jula

i 2

014

SELAMAT BERKHIDMAT DI TEMPAT BARU

2012-2013 Klinik Kesihatan Mahmoodiah Johor Bharu

2013 sekarang Berkhidmat di Hospital Tumpat.

Lulusan Diploma Penolong Pegawai Farmasi Kolej Sains Kesihatan Bersekutu Sungai Buloh.

1999-2001 Berkhidmat di Klinik Kesihatan Bera 32

2001-2012 Berkhidmat di Klinik Kesihatan Triang

2012-2013 Berkhidmat di Hospital Kuala Krai

2013 sekarang Berkhidmat di Hospital Tumpat

Lulusan Diploma Pembantu Farmasi Makmal & Stor Petaling Jaya

2010-2013 berkhidmat di Hospital Dungun

2013 sekarang berkhidmat di Hospital Tumpat

Lulusan Diploma Penolong Pegawai Farmasi Kolej Universiti MAHSA 2007-2010.

PN MARIYAH HJ MAT, PEN. PEG. FARMASI U29

PN SITI NORNABILAH AB RAHMAN, PEN. PEG. FARMASI U29

PN WAN NURUL ATIKAH WAN MAMAT, PEN. PEG. FARMASI U29

Bertukar ke

HRPZ II, pada

Februari 2013

Bertugas di KK

Penambang, Kota Bharu

bermula Mei 2013

Bertukar ke BPFK, Petaling

Jaya pada November 2013

Bertugas di KK Kg Lalang,

Baling, Kedah bermula Mac 2014

PN NAZMI LIANA AZMI PEG. FARMASI U44

PN YU YONG KING PEG. FARMASI U44

EN MOHD AZNAN RAJID PEN. PEG. FARMASI U29

PN RAJA RAHBANIAH RAJA JAAFAR, PEN. PEG.

FARMASI U29

Suntingan & susunan : Ummi Wahida, Rizalmie & Siti Hamisah 11

12

12

13

Page 13

13

14

MAJLIS PERPISAHAN

PF U44 PN YU YONG KING, PPF U29 PN RAJA RAHBANIAH & PPF U29 MOHD AZNAN RAJID

14

15

EN. EH CHOI

A/L CHAU ONN

Duta Kenali Ubat Anda,

Tumpat

15

16

PENYELARAS AKREDITASI:

PF Siti PAUZIAH

16

PENYELARAS ADUAN

PELANGGAN :

pf Siti FATIMAH

KETUA PENGAWAL

DOKUMEN iso : pf UMMI WAHIDA

Wakil Pengurusan ISO:

PF Siti Hamisah

17

17

18

18

19

19

Penyelaras : Pn. Siti Pauziah

Ketua Editor: Pn. Siti Hamisah

Editor

Pn. Ummi Wahida

Pn. Siti Fatimah

Cik Owi Siew Ai

Pn. Hasanah

En. Mohd Rizalmie

Pn. Mariyah